All Insights and Resources

Manufacturing

Virica Biotech Receives Funding from Canadian Government to Support the Re-Development of the Worlds First Ever Gene Therapy

18 May 2022

Virica Biotech Receives Funding from Canadian Government to Support the Re-Development of the Worlds First Ever Gene Therapy

Virica Biotech has announced collaboration

Chimeric and WuXi ATU Partner to Advance CAR-T Manufacturing Pipelines

13 April 2022

Chimeric and WuXi ATU Partner to Advance CAR-T Manufacturing Pipelines

Chimeric has announced they have

Accelerating ATMPs Speed to Market Through Flexible and Future-Proofed Manufacturing Capacity Solutions

11 April 2022

Accelerating ATMPs Speed to Market Through Flexible and Future-Proofed Manufacturing Capacity Solutions

Pete Makowenskyj the Director of

Catapult’s Cell and Gene Therapies Vision for UK as a Global Delivery Leader

31 March 2022

Catapult’s Cell and Gene Therapies Vision for UK as a Global Delivery Leader

Cell and Gene Therapy Catapult

POPULAR NEWS ITEMS

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

26 May 2022

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

25 May 2022

Key Takeaways from ASGCT 2022

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

24 May 2022

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

Genetically Engineered Product Guidelines put under the FDA Microscope

22 March 2022

Genetically Engineered Product Guidelines put under the FDA Microscope

Gene edited and CAR-T cell

Oxford Biomedica Expands AAV Business into Boston

14 March 2022

Oxford Biomedica Expands AAV Business into Boston

News

Celyad Oncology’s CAR-T Phase Ib Trial put on FDA Clinical Hold in Latest Setback

9 March 2022

Celyad Oncology’s CAR-T Phase Ib Trial put on FDA Clinical Hold in Latest Setback

News

WuXi and OXGENE Launch TESSA Technology to Meet Cell and Gene Therapy Scalability Demand

9 March 2022

WuXi and OXGENE Launch TESSA Technology to Meet Cell and Gene Therapy Scalability Demand

News

RECOMENDED TOPICS

Industry Insights

POPULAR NEWS ITEMS

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Key Takeaways from ASGCT 2022

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

logo_mobile_footer

Company

Resources

Network

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

Phacilitate is a part of Clarion Events Limited. © Phacilitate 2022